Lawrence Bruno - Dec 31, 2022 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role
Chairman and CEO, Director
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Stock symbol
CLB
Transactions as of
Dec 31, 2022
Transactions value $
-$727,531
Form type
4
Date filed
1/4/2023, 03:46 PM
Previous filing
Feb 17, 2022
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Tax liability -$728K -35.9K -25.93% $20.27* 103K Dec 31, 2022 Direct
transaction CLB Common Shares Options Exercise $0 +91.2K +193.25% $0.00 138K Dec 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Options Exercise $0 -91.2K -100% $0.00* 0 Dec 31, 2022 Common Shares 91.2K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.